Lombard Odier Asset Management (Usa) Corp Eli Lilly & CO Transaction History

Lombard Odier Asset Management (Usa) Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $384,930 - $514,982	650 New	650 $505,000
Q1 2021 May 17, 2021	SELL	$164.32 - $212.72 $266,527 - $345,031	-1,622 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $211,606 - $280,005	1,622 New	1,622 $274,000
Q2 2020 Aug 14, 2020	SELL	$136.42 - $164.18 $2.35 Million - $2.82 Million	-17,200 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$119.05 - $147.35 $2.05 Million - $2.53 Million	17,200 New	17,200 $2.39 Million

4,011

751M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $755B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Usa) Corp, based on Form 13F filings with the SEC.

Stay updated on Lombard Odier Asset Management (Usa) Corp with notifications on news.